(HealthDay)—Six inflammatory proteins are upregulated in plasma several years before diagnosis of ulcerative colitis, according to a report published in the November issue of Gastroenterology.
Nov 25, 2021
0
2
(HealthDay)—The pooled prevalence of primary sclerosing cholangitis (PSC) is 2.16 percent in patients with inflammatory bowel disease (IBD), according to a review published in the December issue of Gastroenterology.
Nov 24, 2021
0
1
APO-2 (Aposec) is a secretome-based trial preparation derived from stressed peripheral blood mononuclear cells. APO-2 was shown to be safe and effective in a multinational Phase I study in patients with diabetic foot ulcers ...
Nov 11, 2021
0
19
Here's some comforting news for people who struggle with inflammatory bowel disease and worry that the immune-suppressing drugs they must take might blunt their response to COVID-19 vaccines: New research finds vaccination ...
Nov 4, 2021
0
11
The effectiveness of fecal microbiota transplantation (FMT) in treating ulcerative colitis depends on a small set of beneficial bacterial strains, suggests a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Oct 12, 2021
0
21
(HealthDay)—The global prevalence of primary sclerosing cholangitis (PSC) ranges from 0.96 percent in Crohn disease (CD) to 2.47 percent in ulcerative colitis (UC), according to a review published online Aug. 19 in Gastroenterology.
Sep 27, 2021
0
16
New research being presented at the European Association for the Study of Diabetes (EASD), held online this year (27 Sept-1 Oct), reveals how Belgium's efforts to maintain a diabetic foot care program during the COVID-19 ...
Sep 27, 2021
0
2
A Purdue University engineer's patent-pending invention could improve the quality of life for millions of people suffering from diabetic foot ulcers.
Sep 16, 2021
0
6
There may be good news for the nearly 1 million people battling ulcerative colitis, a type of inflammatory bowel condition with no real cure: Statins, a commonly prescribed cholesterol-lowering drug, seem to be an effective, ...
Sep 16, 2021
0
6
It is not necessary to tailor the medication doses to patients, at thestart of treatment, for patients to have a good effect. This is shown by a new Norwegian study led by Professor Espen A. Haavardsholm.
Sep 9, 2021
0
4
